Wild-type distributions of minimum inhibitory concentrations and epidemiological cut-off values-laboratory and clinical utility

被引:11
|
作者
Kahlmeter, Gunnar [1 ,2 ,3 ]
Turnidge, John [4 ,5 ]
机构
[1] European Comm Antimicrobial Susceptibil Testing EU, Vaxjo, Sweden
[2] Swedish Reference Lab Phenotyp Susceptibil Testing, Vaxjo, Sweden
[3] EUCAST Dev Lab, Vaxjo, Sweden
[4] European Comm Antimicrobial Susceptibil Testing EU, Document & Tech Support, Vaxjo, Sweden
[5] Univ Adelaide, Sch Biol Sci, Adelaide, Australia
关键词
ECOFF; epidemiological cut-off value; antimicrobial susceptibility testing; AST; phenotypic wild-type distribution; ECV; MYCOBACTERIUM-TUBERCULOSIS; SUSCEPTIBILITY; EUCAST; BREAKPOINTS; BACTERIA; ECOFFS;
D O I
10.1128/cmr.00100-22
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The characterization of wild-type minimum inhibitory concentration (MIC) and zone diameter distributions with the setting of epidemiological cut-off values (ECOFFs or ECVs) provides a reference for the otherwise relative MIC values in the international system for antimicrobial susceptibility testing. Distributions of MIC values for a species and an agent follow a log-normal distribution, which in the absence of resistance mechanisms is monomodal and designated wild type (WT). The upper end of the WT distribution, the ECOFF, can be identified with statistical methods. In the presence of phenotypically detectable resistance, the distribution has at least one more mode (the non-WT), but despite this, the WT is most often identifiable using the same methods. The ECOFF provides the most sensitive measure of resistance development in a species against an agent. The WT and non-WT modes are independent of the organism ' s response to treatment, but when the European Committee on Antimicrobial Susceptibility Testing (EUCAST) determines the clinical breakpoints, the committee avoids breakpoints that split WT distributions of target species. This is to avoid the poorer reproducibility of susceptibility categorization when breakpoints split major populations but also because the EUCAST has failed to identify different clinical outcomes for isolates with different MIC values inside the wild-type distribution. In laboratory practice, the ECOFF is used to screen for and exclude resistance and allows the comparison of resistance between systems with different breakpoints from different breakpoint organizations, breakpoints evolving over time, and different breakpoints between human and animal medicine. The EUCAST actively encourages colleagues to question MIC distributions as presented on the website (https://www.eucast.org/mic_and_zone_distributions_and_ecoffs) and to contribute MIC and inhibition zone diameter data.
引用
收藏
页数:14
相关论文
共 43 条
  • [11] Wild-type minimum effective concentration distributions and epidemiologic cutoff values for caspofungin and Aspergillus spp. as determined by Clinical and Laboratory Standards Institute broth microdilution methods
    Pfaller, Michael A.
    Boyken, Linda
    Hollis, Richard J.
    Kroeger, Jennifer
    Messer, Shawn A.
    Tendolkar, Shailesh
    Diekema, Daniel J.
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2010, 67 (01) : 56 - 60
  • [12] Epidemiological cut-off values for Vibrio parahaemolyticus calculated from minimal inhibitory concentration data generated at 35 and 28°C
    Smith, Peter
    Joseph, Andrew
    Baker-Austin, Craig
    Kang, Nisha
    Baron, Sandrine
    Le Devendec, Laetitia
    Jouy, Eric
    Chisnall, Thomas
    Davies, Alistair R.
    Schwarz, Stefan
    Fessler, Andrea T.
    Ahrens, Tanja
    Jahnen, Johanna
    Alter, Thomas
    Fleischmann, Susanne
    Hammerl, Jens Andre
    Jaeckel, Claudia
    Gieseker, Charles M.
    Crosby, Tina C.
    Kittel, Elliott C.
    Miller, Ron A.
    Alexander, Trevor
    Carranza, Kayleigh
    Burbick, Claire B.
    Ching, Biyun
    Soh, Jun Heng
    Chng, You Rong
    Wong, Wai Kwan
    Fernandez, Charlene J.
    Chang, Siow Foong
    Verner-Jeffreys, David
    Powell, Andy
    DISEASES OF AQUATIC ORGANISMS, 2024, 160 : 127 - 134
  • [13] Burkholderia pseudomallei multi-centre study to establish EUCAST MIC and zone diameter distributions and epidemiological cut-off values
    Karatuna, O.
    Dance, D. A. B.
    Matuschek, E.
    Ahman, J.
    Turner, P.
    Hopkins, J.
    Amornchai, P.
    Wuthiekanun, V
    Cusack, T-P
    Baird, R.
    Hennessy, J.
    Norton, R.
    Armstrong, M.
    Zange, S.
    Zoeller, L.
    Wahab, T.
    Jacob, D.
    Grunow, R.
    Kahlmeter, G.
    CLINICAL MICROBIOLOGY AND INFECTION, 2021, 27 (05) : 736 - 741
  • [14] The utility of novel CGM metrics in the LGA newborn prediction in women with type 1 diabetes - assessment of the cut-off values
    Sibiak, Rafal
    Mrzewka-Rogacz, Beata
    Gutaj, Pawel
    Mantaj, Urszula
    Wender-Ozegowska, Ewa
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2022, 128 : S21 - S22
  • [15] Vibrio ordalii antimicrobial susceptibility testing-Modified culture conditions required and laboratory-specific epidemiological cut-off values
    Poblete-Morales, Matias
    Irgang, Rute
    Henriquez-Nunez, Hernan
    Toranzo, Alicia E.
    Kronvall, Goran
    Avendano-Herrera, Ruben
    VETERINARY MICROBIOLOGY, 2013, 165 (3-4) : 434 - 442
  • [16] Wild-type MIC distributions and epidemiologic cutoff values for fluconazole and Candida: Time for new clinical breakpoints?
    Pfaller M.A.
    Diekema D.J.
    Current Fungal Infection Reports, 2010, 4 (3) : 168 - 174
  • [17] Wild-Type MIC Distribution and Epidemiological Cutoff Values for Aspergillus fumigatus and Three Triazoles as Determined by the Clinical and Laboratory Standards Institute Broth Microdilution Methods
    Pfaller, M. A.
    Diekema, D. J.
    Ghannoum, M. A.
    Rex, J. H.
    Alexander, B. D.
    Andes, D.
    Brown, S. D.
    Chaturvedi, V.
    Espinel-Ingroff, A.
    Fowler, C. L.
    Johnson, E. M.
    Knapp, C. C.
    Motyl, M. R.
    Ostrosky-Zeichner, L.
    Sheehan, D. J.
    Walsh, T. J.
    JOURNAL OF CLINICAL MICROBIOLOGY, 2009, 47 (10) : 3142 - 3146
  • [18] Wild-type MIC distributions and epidemiological cutoff values for 5-flucytosine and Candida species as determined by EUCAST broth microdilution
    Delma, Fatima Zohra
    Melchers, Willem J. G.
    Verweij, Paul E.
    Buil, Jochem B.
    JAC-ANTIMICROBIAL RESISTANCE, 2024, 6 (05):
  • [19] Triazole and Echinocandin MIC Distributions with Epidemiological Cutoff Values for Differentiation of Wild-Type Strains from Non-Wild-Type Strains of Six Uncommon Species of Candida
    Pfaller, Michael A.
    Castanheira, Mariana
    Diekema, Daniel J.
    Messer, Shawn A.
    Jones, Ronald N.
    JOURNAL OF CLINICAL MICROBIOLOGY, 2011, 49 (11) : 3800 - 3804
  • [20] Determination of serum holotranscobalamin concentrations with the AxSYM active B12 assay: cut-off point evaluation in the clinical laboratory
    Bamonti, Fabrizia
    Moscato, Giovanna Antonella
    Novembrino, Cristina
    Gregori, Dario
    Novi, Claudia
    De Giuseppe, Rachele
    Galli, Claudio
    Uva, Valentina
    Lonati, Silvia
    Maiavacca, Rita
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2010, 48 (02) : 249 - 253